Lido Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $287K | Sell |
1,312
-1,532
| -54% | -$335K | ﹤0.01% | 1226 |
|
|
2025
Q1 | $637K | Buy |
2,844
+87
| +3% | +$19.5K | ﹤0.01% | 877 |
|
|
2024
Q4 | $903K | Sell |
2,757
-38
| -1% | -$12.4K | ﹤0.01% | 738 |
|
|
2024
Q3 | $839K | Buy |
2,795
+1,803
| +182% | +$541K | ﹤0.01% | 717 |
|
|
2024
Q2 | $327K | Sell |
992
-8
| -0.8% | -$2.64K | ﹤0.01% | 965 |
|
|
2024
Q1 | $396K | Buy |
1,000
+40
| +4% | +$15.8K | ﹤0.01% | 882 |
|
|
2023
Q4 | $338K | Buy |
960
+172
| +22% | +$60.5K | ﹤0.01% | 885 |
|
|
2023
Q3 | $296K | Buy |
788
+106
| +16% | +$39.8K | ﹤0.01% | 825 |
|
|
2023
Q2 | $261K | Buy |
+682
| New | +$261K | ﹤0.01% | 898 |
|
|
2022
Q4 | – | Sell |
-1,059
| Closed | -$260K | – | 902 |
|
|
2022
Q3 | $260K | Sell |
1,059
-1,526
| -59% | -$375K | ﹤0.01% | 712 |
|
|
2022
Q2 | $781K | Buy |
2,585
+13
| +0.5% | +$3.93K | 0.01% | 362 |
|
|
2022
Q1 | $1.06M | Buy |
2,572
+62
| +2% | +$25.5K | 0.01% | 344 |
|
|
2021
Q4 | $1.18M | Buy |
2,510
+409
| +19% | +$192K | 0.01% | 346 |
|
|
2021
Q3 | $891K | Sell |
2,101
-159
| -7% | -$67.4K | 0.01% | 389 |
|
|
2021
Q2 | $812K | Sell |
2,260
-76
| -3% | -$27.3K | 0.01% | 374 |
|
|
2021
Q1 | $658K | Buy |
2,336
+17
| +0.7% | +$4.79K | 0.01% | 383 |
|
|
2020
Q4 | $656K | Sell |
2,319
-474
| -17% | -$134K | 0.01% | 370 |
|
|
2020
Q3 | $768K | Buy |
2,793
+1,421
| +104% | +$391K | 0.02% | 277 |
|
|
2020
Q2 | $312K | Sell |
1,372
-152
| -10% | -$34.6K | 0.01% | 381 |
|
|
2020
Q1 | $232K | Buy |
1,524
+91
| +6% | +$13.9K | 0.01% | 428 |
|
|
2019
Q4 | $215K | Buy |
+1,433
| New | +$215K | 0.01% | 544 |
|